Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Netherlands Heart Journal
Published in: Netherlands Heart Journal 1/2012

Open Access 01-01-2012 | Special Article

The pregnant woman with heart disease: management of pregnancy and delivery

Author: P. G. Pieper

Published in: Netherlands Heart Journal | Issue 1/2012

Login to get access

Abstract

Women with heart disease are at risk of cardiac complications during pregnancy and delivery. Risk assessment should be performed in these women, and the management of pregnancy and delivery should be planned accordingly. Depending on the risk, women should be cared for in specialised centres, regional centres or a combination of both. Multidisciplinary teams must be involved in the care of these women. Adequate organisation of care and communication between the team members is important to prevent complications.
Literature
1.
Drenthen W, Boersma E, Balci A, On behalf of the ZAHARA investigators, et al. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J. 2010;31:2124–32.PubMedCrossRef
2.
Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104(5):515–21.PubMedCrossRef
3.
Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Outcome of pregnancy in women with congenital heart disease. A literature review. J Am Coll Card. 2007;49(24):2302–11.CrossRef
4.
Pieper PG, Balci A, van Dijk AP. Pregnancy in women with prosthetic heart valves. Neth Heart J. 2008;16:406–11.PubMedCrossRef
5.
Pieper PG. Pre-pregnancy risk assessment and counselling of the cardiac patient. Neth Heart J 2011; Sep 7 (Epub ahead of print)
6.
Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C et al. ESC guidelines on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology. Eur Heart J. 2011; Aug 26 (Epub ahead of print; doi:10.​1093/​eurheartj/​ehr218)
7.
Thorne S, McGregor A, Nelson-Piercy C. Risk of contraception and pregnancy in heart disease. Heart. 2006;92:1520–5.PubMedCrossRef
8.
CEMACH, London, 2007. Confidential enquiry into maternal and child health. Perinatal Mortality 2005: England, Wales and Northern Ireland.
9.
Deanfield J, Thaulow E, Warnes C, et al. Management of grown up congenital heart disease. Eur Heart J. 2003;24:1035–84.PubMedCrossRef
10.
Newstead-Angel J, Gibson PS. Cardiac drug use in pregnancy: safety, effectiveness and obstetric implications. Expert Rev Cardiovasc Ther. 2009;7:1569–80.PubMedCrossRef
11.
De Wilde JP, Rivers AW, Price DL. A review of the current use of magnetic resonance imaging in pregnancy and safety implications for the fetus. Progr Biophys Mol Biol. 2005;87:335–53.CrossRef
12.
Yap SC, Drenthen W, Pieper PG, et al. On behalf of the ZAHARA Investigators. Risk of complications during pregnancy in women with congenital aortic stenosis. Int J Cardiol. 2008;126:240–6.PubMedCrossRef
13.
Balci A, Drenthen W, Mulder BJ, et al. Pregnancy in women with corrected tetralogy of Fallot: occurrence and predictors of adverse events. Am Heart J. 2011;161:307–13.PubMedCrossRef
14.
Fernandes SM, Arendt KA, Landsberg MJ, et al. Pregnant women with cardiac disease: cardiac, anesthetic and obstetrical implications. Expert Rev Cardiovasc Ther. 2010;8:439–48.PubMedCrossRef
Metadata
Title
The pregnant woman with heart disease: management of pregnancy and delivery
Author
P. G. Pieper
Publication date
01-01-2012
Publisher
Bohn Stafleu van Loghum
Published in
Netherlands Heart Journal / Issue 1/2012
Print ISSN: 1568-5888
Electronic ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-011-0209-y

Other articles of this Issue 1/2012

Netherlands Heart Journal 1/2012 Go to the issue

Imaging in Cardiology

Giant coronary aneurysms: three-dimensional reconstruction

Editor's page

A broken heart: repair needed?

Editorial

Genetics and tailored therapy in cardiovascular disease

Review Article

Individualised therapy of angiotensin converting enzyme (ACE) inhibitors in stable coronary artery disease: overview of the primary results of the PERindopril GENEtic association (PERGENE) study

Original article – E-Learning

Patients with aortic stenosis referred for TAVI: treatment decision, in-hospital outcome and determinants of survival

Case Report

Early double stent thrombosis associated with clopidogrel hyporesponsivenesss

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits